REQUEST A DEMO
Total
USD $0.00
Search more companies

Citrus Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Citrus Pharma Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Citrus Pharma Bt. is a company in Hungary, with a head office in Szeged. The enterprise operates in the Pharmacies and Drug Stores industry. It was established on September 20, 1998. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Citrus Pharma Bt. reported a net sales revenue increase of 5.29% in 2023. Its total assets grew by 7.81% over the same period. In 2023, Citrus Pharma Bt.’s net profit margin decreased by 0.55%.

Headquarters
Rakoczi u. 8.
Szeged; Csongrad; Postal Code: 6725

Contact Details: Purchase the Citrus Pharma Bt. report to view the information.

Website: http://www.webshop-citruspatika.hu

Basic Information
Total Employees:
Purchase the Citrus Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Citrus Pharma Bt. report to view the information.
Registered Capital:
Purchase the Citrus Pharma Bt. report to view the information.
Incorporation Date:
September 20, 1998
Key Executives
Company Performance
Financial values in the chart are available after Citrus Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.29%
Total operating revenue
5.16%
Operating profit (EBIT)
-18.86%
EBITDA
-14.05%
Net Profit (Loss) for the Period
-13.69%
Total assets
7.81%
Total equity
45.33%
Operating Profit Margin (ROS)
-0.94%
Net Profit Margin
-0.55%
Return on Equity (ROE)
-21.33%
Quick Ratio
0.04%
Cash Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?